Cytodyn Inc (CYDY)

[HouseofCards]

Zero efficacy is wrong. The fact that it didn't show statisical significance doesn't mean it showed 0 efficacy. Those aren't the same thing. At day 28 the critically ill population (which is the population the CD20 will look at) Leronlimab showed a 31% reduction in death compared to the standard of care. There were not enough patients and/or it was not enough of a reduction to show statisical significance but that still shows efficacy. It certainly shows efficacy if you compare it to days 7-21, while the drug was in the patient there was a very high reduction in death and as it wore off the benefit started to subside.

It's all here in a table for you.

https://www.cytodyn.com/newsroom/press-releases/detail/533/cytodyn-to-submit-newly-completed-topline-report-of-cd12